[SIME] YoY Quarter Result on 31-Dec-2021 [#2]

Stock
[SIME] SIME DARBY BHD
Announcement Date
16-Feb-2022
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2022
Quarter
31-Dec-2021 [#2]
Profit Trend
QoQ- 46.19%
YoY- -45.5%
Quarter Report
Latest QR
Upcoming QR
SIME's Result
SIME's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 15,548,000 11,292,000 10,536,000 11,243,000 10,209,000 9,423,000 8,815,000 9.91%
PBT 452,000 365,000 481,000 824,000 413,000 308,000 138,000 21.85%
Tax 1,888,000 31,000 -106,000 -156,000 -116,000 29,000 206,000 44.63%
NP 2,340,000 396,000 375,000 668,000 297,000 337,000 344,000 37.62%
-
NP to SH 2,288,000 389,000 345,000 633,000 282,000 317,000 305,000 39.89%
-
Tax Rate -417.70% -8.49% 22.04% 18.93% 28.09% -9.42% -149.28% -
Total Cost 13,208,000 10,896,000 10,161,000 10,575,000 9,912,000 9,086,000 8,471,000 7.68%
-
Net Worth 19,084,799 15,801,519 15,717,239 15,509,785 14,555,098 14,417,778 14,554,140 4.61%
Dividend
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Div 204,480 204,330 272,160 408,152 136,028 136,016 136,020 7.02%
Div Payout % 8.94% 52.53% 78.89% 64.48% 48.24% 42.91% 44.60% -
Equity
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Net Worth 19,084,799 15,801,519 15,717,239 15,509,785 14,555,098 14,417,778 14,554,140 4.61%
NOSH 6,812,157 6,812,157 6,809,918 6,802,537 6,801,447 6,800,839 6,800,839 0.02%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 15.05% 3.51% 3.56% 5.94% 2.91% 3.58% 3.90% -
ROE 11.99% 2.46% 2.20% 4.08% 1.94% 2.20% 2.10% -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 228.11 165.79 154.85 165.28 150.10 138.56 129.61 9.87%
EPS 33.60 5.70 5.10 9.30 4.10 4.70 4.50 39.78%
DPS 3.00 3.00 4.00 6.00 2.00 2.00 2.00 6.98%
NAPS 2.80 2.32 2.31 2.28 2.14 2.12 2.14 4.57%
Adjusted Per Share Value based on latest NOSH - 6,809,918
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 228.24 165.76 154.66 165.04 149.86 138.33 129.40 9.91%
EPS 33.59 5.71 5.06 9.29 4.14 4.65 4.48 39.87%
DPS 3.00 3.00 4.00 5.99 2.00 2.00 2.00 6.98%
NAPS 2.8016 2.3196 2.3072 2.2768 2.1366 2.1165 2.1365 4.61%
Price Multiplier on Financial Quarter End Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 29/12/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 -
Price 2.35 2.30 2.32 2.31 2.22 2.40 2.21 -
P/RPS 1.03 1.39 1.50 1.40 1.48 1.73 1.71 -8.09%
P/EPS 7.00 40.27 45.75 24.82 53.54 51.49 49.28 -27.75%
EY 14.28 2.48 2.19 4.03 1.87 1.94 2.03 38.40%
DY 1.28 1.30 1.72 2.60 0.90 0.83 0.90 6.04%
P/NAPS 0.84 0.99 1.00 1.01 1.04 1.13 1.03 -3.33%
Price Multiplier on Announcement Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 21/02/24 23/02/23 16/02/22 25/02/21 26/02/20 21/02/19 22/02/18 -
Price 2.66 2.28 2.26 2.20 1.99 2.29 2.75 -
P/RPS 1.17 1.38 1.46 1.33 1.33 1.65 2.12 -9.42%
P/EPS 7.92 39.92 44.57 23.64 48.00 49.13 61.32 -28.89%
EY 12.62 2.50 2.24 4.23 2.08 2.04 1.63 40.62%
DY 1.13 1.32 1.77 2.73 1.01 0.87 0.73 7.55%
P/NAPS 0.95 0.98 0.98 0.96 0.93 1.08 1.29 -4.96%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment